Medical Properties Trust (NYSE:MPW) Upgraded to Buy at StockNews.com

Medical Properties Trust (NYSE:MPWGet Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a report issued on Monday.

MPW has been the subject of several other research reports. Truist Financial decreased their price objective on Medical Properties Trust from $26.00 to $23.00 and set a “hold” rating for the company in a report on Thursday, March 24th. Bank of America downgraded Medical Properties Trust from a “buy” rating to a “neutral” rating and set a $21.00 price objective for the company. in a report on Friday, March 11th. Credit Suisse Group decreased their price target on Medical Properties Trust from $27.00 to $26.00 and set an “outperform” rating for the company in a report on Monday, February 14th. Jefferies Financial Group downgraded Medical Properties Trust from a “buy” rating to a “hold” rating and decreased their price target for the stock from $25.00 to $20.00 in a report on Friday, April 22nd. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on Medical Properties Trust from $25.00 to $20.00 in a report on Wednesday, April 27th. Five investment analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Medical Properties Trust has an average rating of “Buy” and an average target price of $23.10.

Shares of Medical Properties Trust stock traded up $0.08 during midday trading on Monday, reaching $18.15. The company had a trading volume of 4,075,651 shares, compared to its average volume of 5,185,785. The stock has a fifty day moving average price of $19.55 and a 200 day moving average price of $21.06. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.64 and a quick ratio of 1.64. The firm has a market cap of $10.89 billion, a PE ratio of 9.71, a P/E/G ratio of 1.53 and a beta of 0.65. Medical Properties Trust has a fifty-two week low of $17.38 and a fifty-two week high of $24.13.

Medical Properties Trust (NYSE:MPWGet Rating) last issued its earnings results on Thursday, April 28th. The real estate investment trust reported $1.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.47 by $0.58. The business had revenue of $409.80 million during the quarter, compared to the consensus estimate of $413.31 million. Medical Properties Trust had a return on equity of 13.25% and a net margin of 70.61%. The firm’s revenue for the quarter was up 13.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.42 earnings per share. As a group, sell-side analysts forecast that Medical Properties Trust will post 1.83 EPS for the current year.

In other news, CEO Edward K. Aldag, Jr. sold 615,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 30th. The stock was sold at an average price of $21.33, for a total transaction of $13,117,950.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO R Steven Hamner sold 285,000 shares of the company’s stock in a transaction that occurred on Thursday, April 7th. The shares were sold at an average price of $21.04, for a total value of $5,996,400.00. Following the transaction, the chief financial officer now directly owns 1,961,214 shares in the company, valued at approximately $41,263,942.56. The disclosure for this sale can be found here. In the last 90 days, insiders sold 906,000 shares of company stock valued at $19,235,910. 1.04% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently modified their holdings of the company. Advisory Services Network LLC lifted its holdings in shares of Medical Properties Trust by 69.2% during the 1st quarter. Advisory Services Network LLC now owns 22,571 shares of the real estate investment trust’s stock valued at $477,000 after purchasing an additional 9,231 shares during the last quarter. Aurora Investment Counsel purchased a new stake in shares of Medical Properties Trust during the 1st quarter valued at $1,635,000. Neuberger Berman Group LLC increased its position in shares of Medical Properties Trust by 3.0% in the 1st quarter. Neuberger Berman Group LLC now owns 2,246,107 shares of the real estate investment trust’s stock valued at $47,483,000 after acquiring an additional 64,557 shares during the period. Toroso Investments LLC increased its position in shares of Medical Properties Trust by 31.5% in the 1st quarter. Toroso Investments LLC now owns 33,115 shares of the real estate investment trust’s stock valued at $700,000 after acquiring an additional 7,927 shares during the period. Finally, BNP Paribas Arbitrage SA increased its position in shares of Medical Properties Trust by 134.5% in the 1st quarter. BNP Paribas Arbitrage SA now owns 580,107 shares of the real estate investment trust’s stock valued at $12,263,000 after acquiring an additional 332,771 shares during the period. Hedge funds and other institutional investors own 82.27% of the company’s stock.

About Medical Properties Trust (Get Rating)

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 431 facilities and roughly 43,000 licensed beds in nine countries and across four continents on a pro forma basis.

Featured Articles

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.